Differential recognition of epitopes present on monomeric and oligomeric forms of gp160 glycoprotein of human immunodeficiency virus type 1 by human monoclonal antibodies.
The mechanism of infectivity neutralization of human immunodeficiency virus type 1 (HIV-1) by Ig is poorly understood. Three human monoclonal antibodies (mAbs 1b12, 2G12 and 2F5) that are able to neutralize primary isolates of HIV-1 in vitro have been shown to act synergistically. In the present study this synergy was analyzed by measuring the epitope accessibility and binding kinetics for these three mAbs with respect to monomeric and oligomeric env protein gp160 IIIB using surface plasmon resonance. The results indicate that oligomerization of gp160 affects the accessibility of some of the epitopes recognized by the mAbs and provide some insight into the mechanism of synergy between different anti-(HIV-1) mAbs.
Zeder-Lutz
G
G
UPR 9021 CNRS Immunochimie des peptides et des virus. Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France.
Hoebeke
J
J
Van Regenmortel
M H
MH
D000911:Antibodies, Monoclonal / Q000737:chemistry* / Q000378:metabolism; D000941:Antigens / Q000378:metabolism; D000939:Epitopes; D019302:HIV Envelope Protein gp160 / Q000737:chemistry*; D006801:Humans; D007700:Kinetics; D008956:Models, Chemical; D011485:Protein Binding; D011487:Protein Conformation; D011994:Recombinant Proteins / Q000737:chemistry / Q000378:metabolism; D020349:Surface Plasmon Resonance; D013997:Time Factors
D000911:Antibodies, Monoclonal; D000941:Antigens; D000939:Epitopes; D019302:HIV Envelope Protein gp160; D011994:Recombinant Proteins